Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

MHLW

- PMLiVE

Werner Baumann to replace Brandicourt at Bayer

Will assume the role of chairman after the former boss jumped ship to Sanofi

- PMLiVE

Rumour mill intensifies around Bayer’s Brandicourt for Sanofi

Could be named Sanofi chief executive as soon as next March

- PMLiVE

Merck takes promotional responsibility for Erbitux in Japan

Currently co-promotes the drug withBristol-Myers Squibb

- PMLiVE

Baxter plans to file long-acting Advate in EU next year

Patients experienced a 95% reduction in bleeds

Novartis building

Novartis’ Japanese subsidiary threatened with suspension

Company failed to report more than 3,200 adverse events among patients taking its drugs

- PMLiVE

NICE heart attack recommendation for Xarelto

Bayer drug on course for another blood clot indication in England and Wales

- PMLiVE

Xarelto gets new atrial fibrillation label in Europe

First oral anticoagulant to gain EU approval in indication

- PMLiVE

Bayer names head of pharma comms in US

Steven Immergut joins from the US FDA

- PMLiVE

Type 2 diabetes market in Asia-Pacific to hit $10.5bn by 2020

Analysts predict increase of $4bn from 2013 figure

- PMLiVE

Japan first to approve Novartis psoriasis drug Cosentyx

Becomes first company to gain approval for an interleukin-17 inhibitor

- PMLiVE

Germany’s IQWiG delivers bad news for Bayer’s Eylea

Says drug provides no additional benefit over Novartis’ rival Lucentis in eye condition

Bayer symbol

Bayer puts research at heart of business growth

Says R&D-to-sales ratio will increase

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links